The Levothyroxine Sodium Market is experiencing rapid transformation, with distribution channels emerging as a crucial element for sustained growth. In 2023, the market is valued at approximately USD 4.29 billion, with projections estimating a reach of USD 6.063 billion by 2035, representing a compound annual growth rate (CAGR) of 3.20%. As the prevalence of thyroid disorders continues to rise...